Hologic Appoints Wayde McMillan to Board

By Bobby Samwell • Sunday, April 06 15:14 • Permanent Link

Hologic, Inc. (NASDAQ: HOLX) has announced the election of Wayde McMillan to its board of directors, effective April 4, 2025. McMillan has an extensive background in finance, having served as the chief financial officer of Solventum Corporation and 3M Company's health care business group. He was also previously the CFO of Insulet Corporation and held leadership positions at Medtronic and Covidien.

Steve MacMillan, Hologic's chairman, president, and CEO, expressed excitement about McMillan joining the board, citing his financial expertise and understanding of the med-tech industry as valuable assets.

Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment.

No specific financial metrics or performance indicators were included in the press release. The market has reacted to these announcements by moving the company's shares -1.3% to a price of $60.86. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.